Jeong CW - Search Results

1

Renal cell carcinoma in end-stage renal disease: Multi-institutional comparative analysis of survival.

Song C, Hong SH, Chung JS, Byun SS, Kwak C, Jeong CW, Seo SI, Jeon HG, Seo IY. Song C, et al. Among authors: jeong cw. Int J Urol. 2016 Jun;23(6):465-71. doi: 10.1111/iju.13084. Epub 2016 Mar 28. Int J Urol. 2016. PMID: 27021929

2

Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma.

Jeong IG, Jeong CW, Hong SK, Kwak C, Lee E, Lee SE. Jeong IG, et al. Among authors: jeong cw. Urology. 2006 Apr;67(4):709-12. doi: 10.1016/j.urology.2005.10.042. Epub 2006 Mar 29. Urology. 2006. PMID: 16566981

3

Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma.

Kwak C, Park YH, Jeong CW, Jeong H, Lee SE, Moon KC, Ku JH. Kwak C, et al. Among authors: jeong h, jeong cw. J Surg Oncol. 2007 Mar 15;95(4):317-23. doi: 10.1002/jso.20669. J Surg Oncol. 2007. PMID: 17066434

4

Characteristics of metastasis as a prognostic factor for immunotherapy in metastatic renal cell carcinoma.

Kwak C, Park YH, Jeong CW, Jeong H, Lee SE, Ku JH. Kwak C, et al. Among authors: jeong h, jeong cw. Tumori. 2007 Jan-Feb;93(1):68-74. doi: 10.1177/030089160709300112. Tumori. 2007. PMID: 17455874

5

No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?

Kwak C, Park YH, Jeong CW, Lee SE, Ku JH. Kwak C, et al. Among authors: jeong cw. Urol Oncol. 2007 Jul-Aug;25(4):310-6. doi: 10.1016/j.urolonc.2006.08.022. Urol Oncol. 2007. PMID: 17628297

6

Metastasectomy without systemic therapy in metastatic renal cell carcinoma: comparison with conservative treatment.

Kwak C, Park YH, Jeong CW, Lee SE, Ku JH. Kwak C, et al. Among authors: jeong cw. Urol Int. 2007;79(2):145-51. doi: 10.1159/000106329. Urol Int. 2007. PMID: 17851285

7

Chronic pulmonary disease negatively influences the prognosis of patients with advanced prostate cancer.

Jeong CW, Ku JH, Kwak C, Kim HH, Lee SE. Jeong CW, et al. World J Urol. 2009 Oct;27(5):643-52. doi: 10.1007/s00345-009-0375-3. Epub 2009 Feb 13. World J Urol. 2009. PMID: 19214529

8

Prostate specific antigen half-time and prostate specific antigen doubling time as predictors of response to androgen deprivation therapy for metastatic prostate cancer.

Park YH, Hwang IS, Jeong CW, Kim HH, Lee SE, Kwak C. Park YH, et al. Among authors: jeong cw. J Urol. 2009 Jun;181(6):2520-4; discussion 2525. doi: 10.1016/j.juro.2009.01.104. Epub 2009 Apr 16. J Urol. 2009. PMID: 19371894

9

Comparison of 30 mg and 40 mg of mitomycin C intravesical instillation in Korean superficial bladder cancer patients: prospective, randomized study.

Jeong CW, Jeon HG, Kwak C, Jeong H, Lee SE. Jeong CW, et al. Among authors: jeong h. Cancer Res Treat. 2005 Feb;37(1):44-7. doi: 10.4143/crt.2005.37.1.44. Epub 2005 Feb 28. Cancer Res Treat. 2005. PMID: 19956509 Free PMC article.

10

Comparison of laparoendoscopic single-site radical nephrectomy with conventional laparoscopic radical nephrectomy for localized renal-cell carcinoma.

Park YH, Park JH, Jeong CW, Kim HH. Park YH, et al. Among authors: jeong cw. J Endourol. 2010 Jun;24(6):997-1003. doi: 10.1089/end.2009.0554. J Endourol. 2010. PMID: 20370595

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters